YU52000A - Jedinjenja meta-azaciklične amino benzojeve kiseline i njihovi derivati, koji su antagonisti integrina - Google Patents

Jedinjenja meta-azaciklične amino benzojeve kiseline i njihovi derivati, koji su antagonisti integrina

Info

Publication number: YU52000A
Authority: YU; Yugoslavia
Prior art keywords: meta; derivatives; benzoic acid; acid compounds; integrin antagonists
Prior art date: 1998-03-04

Application number

YU52000A

Other languages

English (en)

Serbo-Croatian (sh)

Inventor

Thomas Rogers

Peter Ruminski

Original Assignee

G.D. Searle & Co.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-03-04

Filing date

1999-02-22

Publication date

2003-02-28

1999-02-22 Application filed by G.D. Searle & Co. filed Critical G.D. Searle & Co.

2003-02-28 Publication of YU52000A publication Critical patent/YU52000A/sh

Links

239000005557 antagonist Substances 0.000 title abstract 2
102000006495 integrins Human genes 0.000 title abstract 2
108010044426 integrins Proteins 0.000 title abstract 2
150000005415 aminobenzoic acids Chemical class 0.000 title 1
150000001875 compounds Chemical class 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D239/08—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms directly attached in position 2
- C07D239/12—Nitrogen atoms not forming part of a nitro radical
- C07D239/14—Nitrogen atoms not forming part of a nitro radical with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to said nitrogen atoms

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Rheumatology (AREA)
Engineering & Computer Science (AREA)
Physical Education & Sports Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Orthopedic Medicine & Surgery (AREA)
Epidemiology (AREA)
Endocrinology (AREA)
Cardiology (AREA)
Hematology (AREA)
Obesity (AREA)
Pain & Pain Management (AREA)
Heart & Thoracic Surgery (AREA)
Oncology (AREA)
Diabetes (AREA)
Molecular Biology (AREA)
Immunology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Indole Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

YU52000A 1998-03-04 1999-02-22 Jedinjenja meta-azaciklične amino benzojeve kiseline i njihovi derivati, koji su antagonisti integrina YU52000A (sh)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US3427098A	1998-03-04	1998-03-04

Publications (1)

Publication Number	Publication Date
YU52000A true YU52000A (sh)	2003-02-28

Family

ID=21875345

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
YU52000A YU52000A (sh)	1998-03-04	1999-02-22	Jedinjenja meta-azaciklične amino benzojeve kiseline i njihovi derivati, koji su antagonisti integrina

Country Status (29)

Country	Link
EP (1)	EP1060164A1 (fr)
JP (1)	JP2002505323A (fr)
KR (1)	KR20010041584A (fr)
CN (1)	CN1214011C (fr)
AP (1)	AP1244A (fr)
AR (1)	AR018139A1 (fr)
AU (1)	AU753230B2 (fr)
BG (1)	BG104740A (fr)
BR (1)	BR9908470A (fr)
CA (1)	CA2322207A1 (fr)
EA (1)	EA200000804A1 (fr)
EE (1)	EE200000506A (fr)
GE (1)	GEP20033118B (fr)
HR (1)	HRP20000574A2 (fr)
HU (1)	HUP0100865A3 (fr)
ID (1)	ID25591A (fr)
IL (1)	IL137653A0 (fr)
IS (1)	IS5582A (fr)
MY (1)	MY123908A (fr)
NO (1)	NO315703B1 (fr)
NZ (1)	NZ506598A (fr)
OA (1)	OA11530A (fr)
PL (1)	PL342726A1 (fr)
SK (1)	SK13002000A3 (fr)
TR (1)	TR200002542T2 (fr)
UA (1)	UA71906C2 (fr)
WO (1)	WO1999044994A1 (fr)
YU (1)	YU52000A (fr)
ZA (1)	ZA994406B (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9805655D0 (en)	1998-03-16	1998-05-13	Celltech Therapeutics Ltd	Chemical compounds
GB9814414D0 (en)	1998-07-03	1998-09-02	Celltech Therapeutics Ltd	Chemical compounds
GB9821061D0 (en)	1998-09-28	1998-11-18	Celltech Therapeutics Ltd	Chemical compounds
GB9826174D0 (en)	1998-11-30	1999-01-20	Celltech Therapeutics Ltd	Chemical compounds
US6518283B1 (en)	1999-05-28	2003-02-11	Celltech R&D Limited	Squaric acid derivatives
US6455539B2 (en)	1999-12-23	2002-09-24	Celltech R&D Limited	Squaric acid derivates
DE60130910T2 (de)	2000-04-17	2008-07-10	Ucb Pharma, S.A.	Enamin-derivate als zell-adhäsionsmoleküle
US6403608B1 (en)	2000-05-30	2002-06-11	Celltech R&D, Ltd.	3-Substituted isoquinolin-1-yl derivatives
US6545013B2 (en)	2000-05-30	2003-04-08	Celltech R&D Limited	2,7-naphthyridine derivatives
US6921767B2 (en) *	2000-06-15	2005-07-26	Pharmacia Corporation	Cycloalkyl alkanoic acids as integrin receptor antagonists derivatives
CA2417059A1 (fr)	2000-08-02	2002-02-07	Celltech R&D Limited	Derives d'isoquinoline-1-yl substitues en 3
EP1572210A1 (fr) *	2002-12-20	2005-09-14	Pharmacia Corporation	Isomere r de composes d'acides amines beta en tant que derives antagonistes du recepteur des integrines
UA87854C2 (en)	2004-06-07	2009-08-25	Мерк Энд Ко., Инк.	N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators
AU2006257815A1 (en) *	2005-06-10	2006-12-21	Bipar Sciences, Inc.	PARP modulators and treatment of cancer
EP2131861A2 (fr)	2007-03-01	2009-12-16	Mallinckrodt Inc.	Petites molécules photoactives intégrées et leurs utilisations
JP4792124B1 (ja) *	2010-11-15	2011-10-12	エフイートレード株式会社	車両用保護フィルムの型取り方法、及び、車両用保護フィルムの製造方法
IN2015DN00099A (fr)	2012-07-18	2015-05-29	Univ Saint Louis
US8716226B2 (en)	2012-07-18	2014-05-06	Saint Louis University	3,5 phenyl-substituted beta amino acid derivatives as integrin antagonists
ES2864079T3 (es)	2014-05-30	2021-10-13	Pfizer	Derivados de carbonitrilo como moduladores selectivos del receptor de andrógenos
WO2015187774A1 (fr) *	2014-06-04	2015-12-10	Monsanto Technology Llc	Composés d'acide 3,6-dichlorosalicylique et procédés de synthèse associés
HK1244806A1 (zh)	2015-12-30	2018-08-17	Saint Louis University	作為過氧乙醯硝酸整聯蛋白拮抗劑的間氮雜環氨基苯甲酸衍生物
JP7661969B2 (ja)	2020-05-14	2025-04-15	Ｕｂｅ株式会社	１，４，５，６－テトラヒドロピリミジン－２－アミン誘導体
WO2023275715A1 (fr)	2021-06-30	2023-01-05	Pfizer Inc.	Métabolites de modulateurs sélectifs du récepteur des androgènes
JPWO2023085396A1 (fr)	2021-11-12	2023-05-19

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MX9801716A (es) *	1995-08-30	1998-05-31	Searle & Co	Derivados de meta-guanidina, urea, tiourea o acido aminobenzoico azaciclico, como antagonistas de integrina.

1999
- 1999-02-11 ZA ZA9904406A patent/ZA994406B/xx unknown
- 1999-02-22 SK SK1300-2000A patent/SK13002000A3/sk unknown
- 1999-02-22 PL PL99342726A patent/PL342726A1/xx unknown
- 1999-02-22 JP JP2000534538A patent/JP2002505323A/ja active Pending
- 1999-02-22 BR BR9908470-8A patent/BR9908470A/pt not_active Application Discontinuation
- 1999-02-22 EE EEP200000506A patent/EE200000506A/xx unknown
- 1999-02-22 ID IDW20001695A patent/ID25591A/id unknown
- 1999-02-22 CN CNB998035815A patent/CN1214011C/zh not_active Expired - Fee Related
- 1999-02-22 NZ NZ506598A patent/NZ506598A/en unknown
- 1999-02-22 YU YU52000A patent/YU52000A/sh unknown
- 1999-02-22 HU HU0100865A patent/HUP0100865A3/hu unknown
- 1999-02-22 AU AU32947/99A patent/AU753230B2/en not_active Ceased
- 1999-02-22 WO PCT/US1999/003281 patent/WO1999044994A1/fr not_active Ceased
- 1999-02-22 HR HR20000574A patent/HRP20000574A2/hr not_active Application Discontinuation
- 1999-02-22 UA UA2000095148A patent/UA71906C2/uk unknown
- 1999-02-22 EA EA200000804A patent/EA200000804A1/ru unknown
- 1999-02-22 GE GEAP19995537A patent/GEP20033118B/en unknown
- 1999-02-22 EP EP99937927A patent/EP1060164A1/fr active Pending
- 1999-02-22 CA CA002322207A patent/CA2322207A1/fr not_active Abandoned
- 1999-02-22 TR TR2000/02542T patent/TR200002542T2/xx unknown
- 1999-02-22 IL IL13765399A patent/IL137653A0/xx unknown
- 1999-02-22 OA OA1200000238A patent/OA11530A/en unknown
- 1999-02-22 AP APAP/P/2000/001893A patent/AP1244A/en active
- 1999-02-22 KR KR1020007009774A patent/KR20010041584A/ko not_active Ceased
- 1999-03-02 AR ARP990100880A patent/AR018139A1/es unknown
- 1999-03-03 MY MYPI99000772A patent/MY123908A/en unknown
2000
- 2000-08-04 IS IS5582A patent/IS5582A/is unknown
- 2000-08-30 NO NO20004316A patent/NO315703B1/no not_active IP Right Cessation
- 2000-09-01 BG BG104740A patent/BG104740A/xx unknown

Also Published As

Publication number	Publication date
BR9908470A (pt)	2000-12-05
ID25591A (id)	2000-10-19
TR200002542T2 (tr)	2001-05-21
MY123908A (en)	2006-06-30
PL342726A1 (en)	2001-07-02
NZ506598A (en)	2003-07-25
JP2002505323A (ja)	2002-02-19
NO20004316D0 (no)	2000-08-30
NO315703B1 (no)	2003-10-13
IS5582A (is)	2000-08-04
SK13002000A3 (sk)	2001-07-10
EE200000506A (et)	2002-04-15
AU3294799A (en)	1999-09-20
EP1060164A1 (fr)	2000-12-20
AP1244A (en)	2004-02-04
EA200000804A1 (ru)	2001-04-23
HUP0100865A3 (en)	2001-11-28
KR20010041584A (ko)	2001-05-25
ZA994406B (en)	2000-02-11
GEP20033118B (en)	2003-11-25
CA2322207A1 (fr)	1999-09-10
AR018139A1 (es)	2001-10-31
WO1999044994A1 (fr)	1999-09-10
IL137653A0 (en)	2001-10-31
NO20004316L (no)	2000-11-06
CN1291978A (zh)	2001-04-18
OA11530A (en)	2004-05-17
CN1214011C (zh)	2005-08-10
HUP0100865A2 (hu)	2001-08-28
BG104740A (en)	2001-02-28
AU753230B2 (en)	2002-10-10
HRP20000574A2 (en)	2001-08-31
UA71906C2 (en)	2005-01-17
AP2000001893A0 (en)	2000-09-30

Publication	Publication Date	Title
BG104740A (en)	2001-02-28	Meta-azacyclic amino benzoic acid compounds and derivatives thereof being integrin antagonists
FI950309A0 (fi)	1995-01-24	Proliiniamidijohdannaisia
DE69705300D1 (de)	2001-07-26	Cyclopropylalkansäurederivate
DK0894084T3 (da)	2002-10-14	Kanelsyrederivater og deres anvendelse som integrinantagonister
TR200200579T2 (tr)	2002-12-23	Amino-tirazolpiridin türevleri.
ATE297203T1 (de)	2005-06-15	Antithrombotische mitteln
ATE203515T1 (de)	2001-08-15	Meta-substituierte phenylsulphonamidderivate
DE69831868D1 (en)	2006-02-23	Antithrombosemittel
TR200102489T2 (tr)	2002-04-22	3-Fenilpiridin Türevleri ve bunların NK-1 alıcı antagonistler olarak kullanılması
DK0889877T3 (da)	2001-10-01	Meta-substituerede phenylenderivater og deres anvendelse som alfav-beta3-integrin-antagonister eller -inhibitorer
YU35697A (en)	1999-11-22	Substituted 6,6-hetero-bicyclic derivatives
MX9801716A (es)	1998-05-31	Derivados de meta-guanidina, urea, tiourea o acido aminobenzoico azaciclico, como antagonistas de integrina.
EA200200619A1 (ru)	2002-10-31	Непептидильные ингибиторы vla-4-зависимого связывания клеток, применяемые при лечении воспалительных, аутоимунных и респираторных заболеваний
ATE219077T1 (de)	2002-06-15	Endothelin antagoniste
AU4831899A (en)	2000-01-17	5-HT1F agonists
MX9800483A (es)	1998-04-30	Derivados de piperazina y su uso como antagonistas de 5-ht1a.
IL136100A (en)	2005-05-17	Biphenylamidine derivatives and pharmaceutical compositions containing the same
EP1019047A4 (fr)	2001-06-13	Agents antithrombotiques
HRP20010885B1 (en)	2010-07-31	Ethanesulfonyl-piperidine derivatives
EP1027051A4 (fr)	2001-03-07	Agents antithrombotiques
NO20004075L (no)	2000-08-15	Substituerte pyrimidin-2-yloksy-karboksylsyrederivater, fremstilling av disse og deres anvendelse som endotelin- antagonister
ATE222583T1 (de)	2002-09-15	Derivate substituierter amidinonaphthylester
DE69824410D1 (en)	2004-07-15	Antithrombosemittel